Dow Up 0.48% Nasdaq Up 0.43%

ImmunoCellular Therapeutics, Ltd. (IMUC)

-NYSE MKT
0.91 0.00(0.00%) Aug 19, 4:02PM EDT
Prev Close:0.91
Open:0.90
Bid:0.90 x 8300
Ask:0.93 x 800
1y Target Est:3.50
Beta:0.93
Earnings Date:Nov 4 - Nov 10 (Est.)
Day's Range:0.90 - 0.92
52wk Range:0.65 - 4.00
Volume:124,948
Avg Vol (3m):739,373
Market Cap:50.03M
P/E (ttm):N/A
EPS (ttm):-0.13
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for IMUC

Comparison

Symbol% ChgMkt Cap
IMUC 0.00%50.03M
AGENDown 1.50%206.21M
DNDNDown 2.17%209.83M
STML 0.00%148.88M

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):N/A
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :-0.22
Quarterly EPS Est (Sep-14) :-0.06
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

ImmunoCellular Therapeutics, Ltd., a clinical-stage biotechnology company, develops immune-based therapies for the treatment of brain and ovarian cancers. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback